As various countries contend with a second wave of COVID-19 outbreaks, many emerging markets are pinning their hopes on a vaccine that will allow them to confidently reopen their economies without the fear of health services being overwhelmed, Oxford Business Group (OBG) has said in its latest report. With 20 million people infected globally and 735,000 virus-related deaths as of August 10, it is becoming increasingly clear that a vaccine ...